The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 260.00
Bid: 220.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 80.00 (36.364%)
Open: 260.00
High: 260.00
Low: 260.00
Prev. Close: 260.00
SPSC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New contract awards

24 Jan 2022 07:00

RNS Number : 3001Z
Spectra Systems Corporation
24 January 2022
 

Spectra Systems Corporation

24 January 2022

 

Spectra Systems Corporation ("Spectra")

New contract awards

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, brand protection technologies and gaming security software, is pleased to announce three new contract awards.

New Banknote Authentication Revenues

Spectra received an additional order for covert materials from its largest central bank customer, increasing this year's initial order by 20%. This increase in order size brings the aggregate order for the current year to 75% of last year's record order size.

In addition to the increased order for covert materials, the customer renewed its sensor service contract at nearly double its historical annual value. This service contract will continue through the deployment of the new sensors which are currently being developed (announced on 2 February 2021) and will overlap with an anticipated service contract specific to the new generation of sensors.

Software Security

Finally, Spectra's Secure Transaction Group has entered into a new contract for an existing USA state lottery customer worth at least $500,000 for the ten-year contract period.

In total, these three new contracts will generate $700,000 of additional unforecasted revenue for the 2022 calendar year.

Dr. Nabil Lawandy, Chief Executive Officer, stated: "We are delighted to announce these new contract awards which deliver further growth in revenues from existing customers across materials, service and software business lines. The increase in materials orders from our largest central bank customer further bolsters the need for reserve currency banknotes."

 

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer

Tel: +1 (0)401 274 4700

 

WH Ireland Limited (Nominated Adviser and Broker)

Chris Fielding (Managing Director, Corporate Finance)

Andrew de Andrade (Executive, Corporate Finance) 

 

Allenby Capital Limited (Joint Broker)

Nick Naylor/James Reeve (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking) 

Tel: +44 (0)20 7220 1650

 

 

 

Tel: +44 (0)20 3328 5665

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTFLFIRLVIVFIF
Date   Source Headline
26th Jul 20127:00 amRNSShareholder Circular Posted
11th Jul 20127:00 amRNSDepositary Interest Facility & Admission to CREST
29th Jun 20124:17 pmRNSAnnual Financial Report
25th Jun 20127:00 amRNSStatement re share price movement
6th Jun 20127:00 amRNSAcquisition
19th Apr 20127:00 amRNSFinal Results
10th Apr 20127:00 amRNSNotice of Results
14th Feb 20127:00 amRNSDirectorate Change
10th Feb 20127:00 amRNSDirectorate Change
30th Sep 20117:00 amRNSInterim Results for the 6 months ended 30 Jun 2011
4th Aug 20117:00 amRNSShareholder Notifications
1st Aug 20117:00 amRNSShareholder Notifications
25th Jul 20117:00 amRNSFirst Day of Dealings on AIM
30th Apr 20097:51 amRNSNet Asset Value(s)
29th Apr 20097:41 amRNSNet Asset Value(s)
28th Apr 20097:48 amRNSNet Asset Value(s)
27th Apr 20098:04 amRNSNet Asset Value(s)
24th Apr 20097:42 amRNSNet Asset Value(s)
23rd Apr 20097:36 amRNSNet Asset Value(s)
22nd Apr 20097:48 amRNSNet Asset Value(s)
21st Apr 20097:38 amRNSNet Asset Value(s)
20th Apr 20097:49 amRNSNet Asset Value(s)
17th Apr 20098:08 amRNSNet Asset Value(s)
16th Apr 20098:09 amRNSNet Asset Value(s)
15th Apr 20098:03 amRNSNet Asset Value(s)
14th Apr 20098:00 amRNSNet Asset Value(s)
14th Apr 20097:00 amRNSNet Asset Value(s)
9th Apr 20097:52 amRNSNet Asset Value(s)
8th Apr 20097:59 amRNSNet Asset Value(s)
7th Apr 20097:57 amRNSNet Asset Value(s)
6th Apr 20098:20 amRNSNet Asset Value(s)
3rd Apr 20097:49 amRNSNet Asset Value(s)
2nd Apr 20097:50 amRNSNet Asset Value(s)
1st Apr 20097:48 amRNSNet Asset Value(s)
31st Mar 20097:51 amRNSNet Asset Value(s)
30th Mar 20097:49 amRNSNet Asset Value(s)
27th Mar 20098:00 amRNSNet Asset Value(s)
26th Mar 20097:54 amRNSNet Asset Value(s)
25th Mar 20097:39 amRNSNet Asset Value(s)
24th Mar 20098:46 amRNSNet Asset Value(s)
23rd Mar 20097:55 amRNSNet Asset Value(s)
20th Mar 20098:12 amRNSNet Asset Value(s)
19th Mar 20097:59 amRNSNet Asset Value(s)
18th Mar 20097:45 amRNSNet Asset Value(s)
17th Mar 20098:00 amRNSNet Asset Value(s)
16th Mar 20099:28 amRNSTotal Redemption
16th Mar 20098:03 amRNSNet Asset Value(s)
13th Mar 20097:58 amRNSNet Asset Value(s)
12th Mar 20097:55 amRNSNet Asset Value(s)
9th Mar 20097:58 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.